A press conference at the White House on Thursday, November 6, where US President Donald Trump announced a new deal with drugmakers to expand access and cut prices for popular obesity medications like Zepbound and Wegovy, was briefly interrupted after a pharmaceutical executive, identified as Gordon Findlay, suddenly collapsed behind the president. Officials and medical personnel rushed to aid Findlay, and members of the press were promptly escorted out of the Oval Office. The cause of the collapse remains unclear. “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The press conference will resume shortly.” White House Press Secretary Karoline Leavitt later said in a statement. Donald Trump Blames Government Shutdown After Democrats Sweep Key Races Across US, Denies Personal Responsibility.

Pharmaceutical Executive Collapses Next to Donald Trump During White House Event

TruLY Score by LatestLY
Rating:3

TruLY Score 3 – Believable; Needs Further Research | On a Trust Scale of 0-5 this article has scored 3 on LatestLY, this article appears believable but may need additional verification. It is based on reporting from news websites or verified journalists (X Account of Journalist Laura Ingraham), but lacks supporting official confirmation. Readers are advised to treat the information as credible but continue to follow up for updates or confirmations

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)